Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Radiation Therapy With Concurrent Sorafenib for Hepatocellular Carcinoma Not Responding to Transarterial Chemoembolization

NCT01618253 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT01618253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01618253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Radiation Therapy With Concurrent Sorafenib for Hepatocellular Carcinoma Not Responding to Transarterial Chemoembolization
Lead sponsor
Medical College of Wisconsin
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2012
Completion date
June 30, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer, hepatocellular carcinoma, hepatoma, liver cancer